Post-kala-azar dermal Leishmaniasis in two different clinical contexts

An Bras Dermatol. 2015 May-Jun;90(3 Suppl 1):108-10. doi: 10.1590/abd1806-4841.20153373.

Abstract

In Brazil, visceral Leishmaniasis is caused by Leishmania chagasi. The development of cutaneous lesions in visceral leishmaniasis patients has been described in two different clinical contexts. Patients with compromised immunity can develop skin lesions as a direct consequence of a current visceral disease. Equally, patients with a history of kala-azar and progressive, immune improvement occasionally develop skin lesions as a consequence of immune reconstitution inflammatory syndrome. These cases manifest in similar fashion to the classic form of post-kala-azar dermal Leishmaniasis. We describe different cases that exemplify these two clinical presentations.

Publication types

  • Case Reports

MeSH terms

  • AIDS-Related Opportunistic Infections / drug therapy
  • AIDS-Related Opportunistic Infections / immunology*
  • Adult
  • Amphotericin B / therapeutic use
  • Antiprotozoal Agents / therapeutic use
  • Antiretroviral Therapy, Highly Active / adverse effects
  • HIV Infections / drug therapy
  • Humans
  • Leishmaniasis, Cutaneous / drug therapy
  • Leishmaniasis, Cutaneous / immunology*
  • Leishmaniasis, Visceral / drug therapy
  • Leishmaniasis, Visceral / immunology*
  • Male

Substances

  • Antiprotozoal Agents
  • Amphotericin B